Byetta Fallout Hits Novo Nordisk (That Pancreatitis Scare)

This morning Novo Nordisk announced that the FDA has scheduled an advisory committee meeting for its new Liraglutide once-daily GLP-1 drug, currently awaiting FDA approval. Believe it or not, this is huge news - with the potential to make or bre...
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs